Breaking News Instant updates and real-time market news.

FINL

Finish Line

$10.42

-0.25 (-2.34%)

, NKE

Nike

$52.46

-1.273 (-2.37%)

10:33
08/29/17
08/29
10:33
08/29/17
10:33

Analysts say run from Finish Line after profit warning

Shares of Finish Line (FINL) are sliding after the shoe retailer reported downbeat preliminary second quarter results and cut its outlook for fiscal 2018. Following the announcement, several Wall Street analysts cut their ratings on the stock to sell-equivalent ratings. PRELIMINARY RESULTS: Last night, Finish Line reported preliminary second quarter earnings per share of 8c-12c and revenue of $469.4M, both below consensus of 38c and $477.18M, respectively. The company also reported preliminary second quarter same-store sales to be down 4.6%, and cut its 2018 adjusted earnings per share view to 50c-60c from $1.12-$1.23. Further, Finish Line sees third quarter adjusted losses per share of (40c)-(32c), and same-store sales down 3%-5% for the quarter. SELL FINISH LINE: In a research note to investors, Buckingham analyst Scott Krasik downgraded Finish Line to Underperform from Neutral and lowered his price target to $5 from $14 after the company pre-announced a second quarter miss and lowered second half 2018 guidance. The analyst said he is incrementally more concerned with the company's ability to re-accelerate sales and margin trends given slower growth trends in athletic footwear overall and increased risk from expanded competition as Finish Line's assortments are less differentiated than Foot Locker's (FL). Further, Krasik told investors that he estimates Finish Line will generate only a modest amount of free cash flow the next two years that could put its dividend at risk. With the athletic footwear market in a downturn and the future for brick and mortar retailers uncertain at best, it is unclear how Finish Line can re-accelerate growth in the next two to three years, he contended. His peer at Citi also downgraded the stock to Sell from Neutral and lowered her price on the shares to $5 from $14. Analyst Kate McShane believes the competitive environment among athletic retailers "has only become more difficult" and Finish Line suffers from being a smaller mall- based chain relative to Dick's Sporting Goods (DKS) and Foot Locker. Additionally, Deutsche Bank analyst Paul Trussell cut Finish Line's rating to Sell saying that last night's negative pronouncement highlight that increased promotional levels in the athletic footwear marketplace are pressuring both sales and margin. The analyst told investors that he believes the space could be in only the early innings of an "elongated lull in trends" and thinks Finish Line has a "weak real estate position" as a primarily mall-based destination. FBR Capital also downgraded Finish Line to Neutral from Buy this morning. OTHERS TO WATCH: Foot Locker, Under Armour (UA; UAA) and Nike (NKE) are all under pressure this morning following Finish Line's preliminary results. Jefferies analyst Randal Konik argued that Finish Line's second quarter miss and guidance cut support his recent downgrade of Nike shares to Hold as they are a "clear negative read" for the latter. Finish Line's business is heavily leveraged to Nike, which accounted for 71% of merchandise purchases in 2017, Konik noted. With both Finish Line and Foot Locker now having significantly missed second quarter expectations and lowering their second half of the year expectations, the analysts believes that he can "logically surmise" that Nike's two largest categories - running and basketball - remain under pressure and are continuing to decelerate. PRICE ACTION: In morning trading, shares of Finish Line have dropped over 21% to $8.18, while Nike's stock has slipped more than 2% to $52.46.

FINL

Finish Line

$10.42

-0.25 (-2.34%)

NKE

Nike

$52.46

-1.273 (-2.37%)

FL

Foot Locker

$35.34

-0.36 (-1.01%)

UA

Under Armour

$15.24

-0.54 (-3.42%)

UAA

Under Armour

$16.32

-0.61 (-3.60%)

  • 03

    Oct

  • 04

    Oct

FINL Finish Line
$10.42

-0.25 (-2.34%)

08/29/17
BUCK
08/29/17
DOWNGRADE
Target $5
BUCK
Underperform
Finish Line downgraded to Underperform from Neutral at Buckingham
Buckingham analyst Scott Krasik downgraded Finish Line (FINL) to Underperform and slashed its price target to $5 from $14 after the company preannounced a Q2 miss and lowered second half 2018 guidance. Krasik said he is concerned with Finish Line's ability to reaccelerate sales and margin trends due to slower growth trends in the athletic footwear category and increased risk from expanded competition as its assortments are less differentiated than Foot Locker's (FL).
08/29/17
ADAM
08/29/17
NO CHANGE
Target $8
ADAM
Hold
Finish Line price target lowered to $8 from $14 at Canaccord
Canaccord analyst Camilo Lyon lowered his price target on Finish Line (FINL) to $8 from $14 after the company preannounced weak Q2 results and lowered guidance for the balance of the year. The analyst said the company is yet another victim of the downturn in the athletic category, which he believes is product driven, starting and ending with Nike (NKE). He said there has been little to no product innovation in more than two years. Once it begins, it could mark a turnaround for the retailers, said Lyon, who maintained his Neutral rating on Finish Line shares.
08/29/17
BARD
08/29/17
NO CHANGE
Target $8
BARD
Neutral
Finish Line price target lowered to $8 from $15 at Baird
Baird analyst Jonathan Komp lowered his price target on Finish Line shares to $8 from $15 after the company pre-released lower than expected Q2 comps and earnings and slashed its outlook for the back half of the year. The company's balance sheet remains "reasonably healthy," but valuation "may not matter until investors gain confidence," said Komp, who keeps a Neutral rating on Finish Line shares.
08/29/17
DBAB
08/29/17
DOWNGRADE
Target $5
DBAB
Sell
Finish Line downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Paul Trussell downgraded Finish Line to Sell and cut his price target for the shares to $5 from $15. Last night's negative pronouncement highlight that increased promotional levels in the athletic footwear marketplace are pressuring both sales and margin, Trussell tells investors in a research note. He believes the space could be in only the early innings of an "elongated lull in trends" and thinks Finish Line has a "weak real estate position" as a primarily mall-based destination. Buckingham, Citi and FBR Capital also downgraded the shares this morning.
NKE Nike
$52.46

-1.273 (-2.37%)

08/29/17
MSCO
08/29/17
NO CHANGE
Target $50
MSCO
Overweight
Foot Locker problems fixable, mostly fashion-related, says Morgan Stanley
Morgan Stanley analyst Jay Sole made his case for keeping an Overweight rating on Foot Locker (FL) in a new note to investors, arguing that the problems that caused the company's "very disappointing" Q2 results were not structural, but "mostly fashion-related" and fixable. He still sees the stock's risk/reward balance skewed to the upside, based on his belief that Foot Locker can defend itself versus Amazon (AMZN), Nike's (NKE) new product pipeline should eventually improve and brands' quicker speed to market "could be a game-changer." However, Sole has lowered his price target on Foot Locker shares to $50 from $65.
08/29/17
JEFF
08/29/17
NO CHANGE
Target $13
JEFF
Buy
Finish Line results support recent Nike downgrade, says Jefferies
Jefferies analyst Randal Konik believes Finish Line's (FINL) Q2 miss and guidance cut support his recent downgrade of Nike (NKE) shares to Hold. Finish Line's preliminary results are a "clear negative read" for Nike, which accounts for more than 70% of the retailer's merchandise, Konik tells investors in a research note. The analyst lowered his price target for Finish Line shares to $13 from $17 and keeps a Buy rating on the name. Last night's results are not overly surprising given the "challenging landscape," the analyst writes.
08/21/17
08/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Hold from Buy at Jefferies, with analyst Randal Konik saying valuation is expensive and the competitive landscape could make share gains and margin expansion difficult. Konik added Adidas' (ADDYY) success in reviving its brand appeal in North America has had a clear impact on Nike shares. 2. Foot Locker (FL) downgraded to Neutral from Buy at UBS and Finish Line (FINL) cut to Sell from Neutral by analyst Michael Binetti, who said Foot Locker's results were worse than the analyst expected and make it tougher to support a thesis that athletic retail will be able to sidestep the structural challenges of the broader sector. Binetti downgraded Finish Line based on the structural risks exposed by Foot Locker exposed in its Q2 report. 3. Barclays analyst Lydia Rainforth downgraded Total (TOT) and Repsol (REPYY) to Equal Weight from Overweight and Statoil (STO) and Eni SpA (E) to Underweight from Equal Weight citing relative valuation. 4. Canadian Solar (CSIQ) downgraded to Underweight from Equal Weight at Barclays, with analyst Jon Windham saying it faces risks from the possible delay of project sales and pricing, soft investor demand for a J-REIT listing in the second half, and risks from the September 22 injury vote in the US ITC 201 trade case. 5. Infosys (INFY) downgraded to Neutral from Overweight at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FL Foot Locker
$35.34

-0.36 (-1.01%)

08/22/17
JEFF
08/22/17
NO CHANGE
JEFF
Weak spending from Hispanic consumers likely temporary, says Jefferies
A team of Jefferies analysts note that several consumer companies have flagged weakness from Hispanic consumers during this earnings season, which they attribute to likely being linked to uncertainty around immigration policy more than a result of a deteriorating economic backdrop. Companies that have been hurt may be due for a rebound as this is assumed to be a short term phenomenon and some have already noted improvement, the team tells investors. Some of the companies that recently have specifically flagged weakness in Hispanic spending include Foot Locker (FL), Murphy USA (MUSA), O'Reilly Automotive (ORLY), Target (TGT), Valvoline (VVV) and Wingstop (WING), the firm noted.
08/29/17
SBSH
08/29/17
DOWNGRADE
Target $5
SBSH
Sell
Finish Line downgraded to Sell from Neutral at Citi
Citi analyst Kate McShane downgraded Finish Line (FINL) to Sell and cut her price target for the shares to $5 from $14 after the company preannounced a Q2 miss and cut its outlook for the year. The shares in premarket trading are down 26%, or $2.71, to $7.71. The marketplace for athletic footwear became more promotional as Q2 progressed but Finish Line's earnings reduction appears worse than the market expected, McShane tells investors in a research note. She believes the competitive environment among athletic retailers "has only become more difficult" and that Finish Line suffers from being a smaller mall- based chain relative to Dick's Sporting Goods (DKS) and Foot Locker (FL). FBR Capital this morning also downgraded Finish Line.
UA Under Armour
$15.24

-0.54 (-3.42%)

08/02/17
JEFF
08/02/17
INITIATION
Target $48
JEFF
Buy
Kohl's assumed with a Buy at Jefferies
Jefferies analyst Randal Konik assumed coverage of Kohl's (KSS) with a Buy rating and $48 price target. The analyst views the valuation as attractive amid negative sentiment and left recent store visits encouraged with trends in Active and the "positive reception" for Under Armour (UA, UAA) product.
08/02/17
SBSH
08/02/17
DOWNGRADE
Target $21
SBSH
Neutral
Under Armour downgraded to Neutral from Buy at Citi
Citi analyst Kate McShane downgraded Under Armour (UAA) and lowered her price target for the shares to $21 from $25. Following yesterday's guide-down, the shares look "too expensive for investors to jump into the name nearer-term," McShane tells investors. She expects the stock will continue trading in a tight range until the end of the year. Under Armour closed yesterday down 9%, or $1.72, to $18.30.
08/02/17
08/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Neutral from Buy at Citi with analyst Kate McShane citing yesterday's guide-down, the shares look "too expensive for investors to jump into the name nearer-term." 2. Burlington Stores (BURL) downgraded to Neutral from Outperform at Credit Suisse with analyst Christian Buss saying that although the fundamentals of the company remain healthy, he sees limited upside to valuation as the multiples stay elevated despite more moderate industry growth prospects. 3. Big 5 Sporting (BGFV) downgraded to Hold from Buy at Deutsche Bank with analyst Mike Baker saying he expected Big Five's sales gains following The Sports Authority liquidation would decelerate at some point, but he notes that "trends fell off faster and to a greater extent than we suspected." 4. Ultimate Software (ULTI) downgraded to Hold from Buy at Deutsche Bank with analyst Nandan Amladi calling the second quarter results "mixed" and prefers to move to the sidelines until growth returns to the mid-20s target and leverage returns to the model. 5. ResMed (RMD) was downgraded to Neutral from Buy at BofA/Merrill and to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/18/17
SBSH
08/18/17
NO CHANGE
Target $81
SBSH
Buy
Foot Locker results and guidance 'greatly disappoints,' says Citi
Citi analyst Kate McShane says Foot Locker's (FL) Q2 results and outlook "greatly disappoints." The company posted its first negative comp since Q4 of 2009, McShane tells investors in a post-earnings research note. Along with Foot Locker, the analyst expects weakness in shares of Nike (NKE) and Finish Line (FINL) as well as Under Armour (UAA, UA) and Dick's Sporting Goods (DKS). McShane currently has a Buy rating on Foot Locker.
UAA Under Armour
$16.32

-0.61 (-3.60%)

08/02/17
08/02/17
NO CHANGE

KeyBanc becoming 'more constructive' on Under Armour
KeyBanc analyst Edward Yruma says he's becoming "more constructive" on Under Armour (UAA). The analyst says that the company's initiatives can cause its EBIT margins to rise, and he thinks that the company has more margin expansion opportunities in active apparel than lululemon (LULU). However, he thinks the company is still facing "difficult trends," and he keeps a Sector Weight rating.

TODAY'S FREE FLY STORIES

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

, ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

20:04
09/24/17
09/24
20:04
09/24/17
20:04
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

ORCL

Oracle

$48.16

0.19 (0.40%)

GPRO

GoPro

$10.75

-0.19 (-1.74%)

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

SIX

Six Flags

$58.96

1.14 (1.97%)

HMC

Honda

$29.91

0.18 (0.61%)

IRBT

iRobot

$76.14

-3.8 (-4.75%)

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 28

    Sep

  • 12

    Oct

  • 24

    Oct

  • 08

    Nov

  • 12

    Jan

NVCR

Novocure

$21.50

-0.1 (-0.46%)

18:27
09/24/17
09/24
18:27
09/24/17
18:27
Hot Stocks
Combination of Novocure Optune with Temozolomide demonstrates five-year survival »

Novocure announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$102.40

-0.09 (-0.09%)

, CMCSA

Comcast

$38.10

0.63 (1.68%)

17:10
09/24/17
09/24
17:10
09/24/17
17:10
Hot Stocks
Box Office Battle: 'Kingsman: The Golden Circle' easily wins weekend »

"Kingsman: The…

TWX

Time Warner

$102.40

-0.09 (-0.09%)

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

SNE

Sony

$37.50

0.04 (0.11%)

FOX

21st Century Fox

$26.43

0.1 (0.38%)

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

LGF.A

Lionsgate

$31.49

0.24 (0.77%)

DIS

Disney

$98.60

-0.29 (-0.29%)

VIAB

Viacom

$27.64

0.24 (0.88%)

VIA

Viacom

$38.00

-0.2 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

  • 22

    Oct

  • 26

    Oct

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

16:41
09/24/17
09/24
16:41
09/24/17
16:41
Periodicals
Amazon affiliate to buy stake in Indian retailer Shoppers Stop, Reuters says »

An affiliate of Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

16:37
09/24/17
09/24
16:37
09/24/17
16:37
Periodicals
Internet giants on the defensive in Washington, Reuters says »

Internet giants,…

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

, UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

16:25
09/24/17
09/24
16:25
09/24/17
16:25
Periodicals
Opposition to new 'Obamacare' repeal bill grows, Reuters reports »

The new proposal by…

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

CNC

Centene

$92.22

1.48 (1.63%)

WCG

WellCare

$167.16

1.1 (0.66%)

CI

Cigna

$182.74

0.61 (0.33%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

AET

Aetna

$153.57

0.18 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SAP

SAP

$110.27

0.64 (0.58%)

16:11
09/24/17
09/24
16:11
09/24/17
16:11
Hot Stocks
SAP announces acquisition of Gigya »

SAP has announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATT

TAT Technologies

$10.70

0.05 (0.47%)

, BA

Boeing

$256.45

0.41 (0.16%)

16:03
09/24/17
09/24
16:03
09/24/17
16:03
Hot Stocks
TAT Technologies awarded APU MRO contract for fleet of Boeing, Airbus »

TAT Technologies (TATT),…

TATT

TAT Technologies

$10.70

0.05 (0.47%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.